BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 2431571)

  • 1. Oxidation of dopa in the skin of black and albino mice.
    Carstam R; Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1986; 66(5):369-74. PubMed ID: 2431571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
    Ito S; Jimbow K; Kato T; Kiyota M; Fujita K
    Acta Derm Venereol; 1983; 63(6):463-7. PubMed ID: 6198833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopa oxidation and tyrosine oxygenation by human melanoma tyrosinase.
    Jergil B; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(6):468-75. PubMed ID: 6198834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosinase activity in the medium of human melanoma cell cultures.
    Jergil B; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(3):205-8. PubMed ID: 6192632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-S-cysteinyldopa as a substrate for tyrosinase.
    Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1980; 60(5):399-402. PubMed ID: 6162310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pronounced formation of 5-OH-dopa at enzymatic oxidation of DOPA in the presence of ascorbic acid.
    Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1981; 61(2):147-8. PubMed ID: 6165191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-OH-dopa, product of and substrate for tyrosinase.
    Agrup G; Rorsman H; Rosengren E
    Acta Derm Venereol; 1982; 62(5):371-76. PubMed ID: 6183884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-regulation of melanin precursors and tyrosinase in human pigment cells: roles of cysteine and glutathione.
    Benathan M; Virador V; Furumura M; Kobayashi N; Panizzon RG; Hearing VJ
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):981-90. PubMed ID: 10644002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidation of 3,4-dihydroxyphenylalanine by connective tissue constituents. Identification of Mycobacterium leprae not related to phenolase activity.
    Kato L; Ishaque M; Adapoe C
    Int J Lepr Other Mycobact Dis; 1976; 44(4):435-42. PubMed ID: 828625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma 5-S-cysteinyldopa concentrations in oculocutaneous albinism.
    Nimmo JE; Hunter JA; Percy-Robb IW; Jay B; Phillips CI; Taylor WO
    Acta Derm Venereol; 1985; 65(2):169-71. PubMed ID: 2408424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of 5-S-glutathionyldopa.
    Carstam R; Edner C; Hansson C; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol Suppl (Stockh); 1986; 126():1-12. PubMed ID: 3103358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of tyrosinase and its mRNA in coat-color mutants of C57BL/10J congenic mice: effects of genic substitution at the agouti, brown, albino, dilute, and pink-eyed dilution loci.
    Tamate HB; Hirobe T; Wakamatsu K; Ito S; Shibahara S; Ishikawa K
    J Exp Zool; 1989 Jun; 250(3):304-11. PubMed ID: 2569495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidation of dopa in human albinism.
    Carstam R; Hansson C; Krook G; Rorsman H; Rosengren E; Wirestrand LE
    Acta Derm Venereol; 1985; 65(5):435-7. PubMed ID: 2416170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diastereomers of 5-S-cysteinyldopa.
    Agrup G; Edholm LE; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(1):59-61. PubMed ID: 6191491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopa and 5-S-cysteinyldopa in the serum of albino, black, and red guinea pigs.
    Hansson C; Agrup G; Rorsman H; Rosengren E
    Acta Derm Venereol; 1980; 60(2):155-56. PubMed ID: 6155023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulating effects of a novel skin-lightening agent, alpha-lipoic acid derivative, on melanin production by the formation of DOPA conjugate products.
    Tsuji-Naito K; Hatani T; Okada T; Tehara T
    Bioorg Med Chem; 2007 Mar; 15(5):1967-75. PubMed ID: 17218103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic controls over melanocyte differentiation: interaction of agouti-locus and albino-locus genetic defects.
    Lamoreux ML; Pendergast P
    J Exp Zool; 1987 Jul; 243(1):71-9. PubMed ID: 2886546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of plant extracts on tyrosinase, L-DOPA oxidation, and melanin synthesis.
    Hwang JH; Lee BM
    J Toxicol Environ Health A; 2007 Mar; 70(5):393-407. PubMed ID: 17454565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical analysis of late stages of pheomelanogenesis: conversion of dihydrobenzothiazine to a benzothiazole structure.
    Wakamatsu K; Ohtara K; Ito S
    Pigment Cell Melanoma Res; 2009 Aug; 22(4):474-86. PubMed ID: 19493317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lag kinetics of tyrosinase: its physiological implications.
    Ramaiah A
    Indian J Biochem Biophys; 1996 Oct; 33(5):349-56. PubMed ID: 9029814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.